Telemedicine catches ROP, NEI study finds

Article

A National Eye Institute (NEI) study found that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

A National Eye Institute (NEI) studyfound that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

Second Sight, Kellog Eye Center finding early success with artificial retina

The study evaluated telemedicine for ROP screening during the care of 1,257 premature babies. Every nine days or so, each infant was screened by an ophthalmologist, who assessed whether referral treatment was warranted. Either immediately before or after that exam, a staff member took photos of babies’ eyes, which were sent to a secure server at the University of Oklahoma, Oklahoma City for evaluation by staff who were trained to recognize signs of severe ROP. The staff then made recommendations on whether the infant should be referred to an eyecare professional for further treatment.

The non-physician image readers in Oklahoma City correctly identified 90 percent of the infants that needed a referral based on examination by an ophthalmologist, and they correctly identified 87 percent of the infants who did not need a referral. The examining ophthalmologists documented 244 infants with ROP who needed a referral on exam, 162 of whom were treated. Of these, non-physician image readers identified ROP that warranted a referral in all but three infants (98 percent).

According to NEI, some signs of ROP appear in about half of infants born at or before 30 weeks, but only five to eight percent of those cases become severe enough to require treatment. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.